In literature, even if some studies have reported high PD-L1 expression in thymomas (ranging from 68 to 94%) and thymic carcinomas (34–88%), conflicting findings exist regarding its association with clinical outcomes [7, 25, 26]. The gene discussed is CD274; the disease is thymoma.